Bradycardia News and Research

RSS
Bradycardia, ("heart slowness"), as applied to adult medicine, is defined as a resting heart rate of under 60 beats per minute, though it is seldom symptomatic until the rate drops below 50 beat/min.
Pacing program can lead to seven-fold reduction in fainting episodes

Pacing program can lead to seven-fold reduction in fainting episodes

Scientists create organ-on-a-chip that can mimic heart's biomechanical properties

Scientists create organ-on-a-chip that can mimic heart's biomechanical properties

Houston Methodist offers world's smallest heart device for patients with bradycardia

Houston Methodist offers world's smallest heart device for patients with bradycardia

Epclusa drug receives FDA approval for treating adult patients with chronic HCV

Epclusa drug receives FDA approval for treating adult patients with chronic HCV

Micra Transcatheter Pacing System approved to treat heart rhythm disorders

Micra Transcatheter Pacing System approved to treat heart rhythm disorders

Bradycardia does not increase cardiovascular disease risk

Bradycardia does not increase cardiovascular disease risk

Bridion injection approved to reverse effects of neuromuscular blocking drugs used during certain types of surgery

Bridion injection approved to reverse effects of neuromuscular blocking drugs used during certain types of surgery

Egalet, Teva sign agreement to commercialize SPRIX Nasal Spray in Israel, Gaza and the West Bank

Egalet, Teva sign agreement to commercialize SPRIX Nasal Spray in Israel, Gaza and the West Bank

Second-line bosutinib offers ‘durable’ response for chronic phase CML patients

Second-line bosutinib offers ‘durable’ response for chronic phase CML patients

Mylan releases Clozapine Orally Disintegrating Tablets in U.S.

Mylan releases Clozapine Orally Disintegrating Tablets in U.S.

Vibration-based technology reduces apneic events, improves critical clinical parameters in premature infants

Vibration-based technology reduces apneic events, improves critical clinical parameters in premature infants

Vibration-based therapy can successfully treat apnea events in preterm infants

Vibration-based therapy can successfully treat apnea events in preterm infants

Allergan settles patent litigation with Amneal related to NAMENDA XR extended release capsules

Allergan settles patent litigation with Amneal related to NAMENDA XR extended release capsules

Egalet announces launch of OXAYDO (oxycodone HCI, USP) Tablets and IMPACT-Rx initiative

Egalet announces launch of OXAYDO (oxycodone HCI, USP) Tablets and IMPACT-Rx initiative

Egalet to present scientific data on SPRIX Nasal Spray at Painweek 2015

Egalet to present scientific data on SPRIX Nasal Spray at Painweek 2015

Research: Patients test drive pacemaker outside the skin before deciding on permanent implant

Research: Patients test drive pacemaker outside the skin before deciding on permanent implant

Cardiac device wearers ought to keep safe distance from smartphones to prevent unwanted painful shocks

Cardiac device wearers ought to keep safe distance from smartphones to prevent unwanted painful shocks

Eisai, Arena complete two Phase 1 registrational trials for once-daily formulation of lorcaserin

Eisai, Arena complete two Phase 1 registrational trials for once-daily formulation of lorcaserin

Egalet announces plans to commercialize SPRIX Nasal Spray and OXAYDO tablets

Egalet announces plans to commercialize SPRIX Nasal Spray and OXAYDO tablets

Egalet announces net revenues of $1.9 million for 2014

Egalet announces net revenues of $1.9 million for 2014